MDCX logo

MDCX
Medicus Pharma Ltd

2,758
Mkt Cap
$13.18M
Volume
1.28M
52W High
$8.94
52W Low
$0.25
PE Ratio
-0.17
MDCX Fundamentals
Price
$0.3201
Prev Close
$0.3151
Open
$0.3117
50D MA
$0.4492
Beta
0.00
Avg. Volume
7.11M
EPS (Annual)
-$1.96
P/B
-160.77
Rev/Employee
$0.00
$24.17
Loading...
Loading...
News
all
press releases
EXCLUSIVE: Penny Stock Medicus Pharma Findings Support Potential In Women's Health Pipeline
Medicus Pharma to present Phase 1 Teverelix data showing dose-dependent estradiol suppression and long-acting profile at AACE 2026.read more...
Benzinga·28d ago
News Placeholder
More News
News Placeholder
EXCLUSIVE: Medicus Pharma Refines Trial Design To Cut Costs, Accelerate Development For Enlarged Prostate Patients
Medicus Pharma submits Phase 2 design for Teverelix, targeting faster data readouts and lower costs in benign prostatic hyperplasiaread more...
Benzinga·1mo ago
News Placeholder
Power Hour Surge: Biotech Cash Floods, Energy Breakouts, and AI Bets Drive the Stocks to Watch into the Close
As Wall Street heads into the final stretch of the trading day, capital flows into biotech financing, clean energy, and emerging technology platforms are shaping the stocks traders are watching most closely into the close and after-hours session. $EONR, $SAFX, $KBLB, $HIMS, $MDCX, $ANTX, $NVO, $MDCX, $RLMD, $SLDB, $ANTX, $EDIT, $DDD
24-7 Market News·2mo ago
News Placeholder
Dow Falls Over 300 Points; Kroger Posts Mixed Results
US stocks down, Dow falls 300 points. Dow traded at 48,411.44, NASDAQ at 22,741.80, S&P 500 at 6,847.63. Energy shares rise, healthcare stocks dip. Kroger posts mixed results. Equities up for Impact...
Benzinga·2mo ago
News Placeholder
Medicus Pharma Stock Swings After Skin Cancer Treatment Results
Medicus Pharma stock surged then slipped after the Phase 2 trial showed a 73% clearance rate for its skin cancer treatment.read more...
Benzinga·2mo ago
<
...
1
>

Latest MDCX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.